Definitive Diagnosis of Mitochondrial Neurogastrointestinal Encephalomyopathy by Biochemical Assays
The DOI matches its Crossref record.
Abstract
Background: Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is caused by mutations in the gene encoding thymidine phosphorylase (TP). The clinical manifestations of MNGIE are recognizable and homogeneous, but in the early stages, the disease is often misdiagnosed. This study assesses the reliability of biochemical assays to diagnose MNGIE. Methods: We studied 180 patients with clinical features suggestive of MNGIE, 14 asymptomatic TP mutation carriers, and 20 controls. TP enzyme activity in the buffy coat was determined by a fixed-time method, and the plasma nucleosides thymidine (dThd) and deoxyuridine (dUrd) were assessed by a gradient-elution reversed phase HPLC method. TP was sequenced through standard procedures in patients who met the clinical criteria for MNGIE. Results:Twenty-five of the 180 patients fulfilled the clinical criteria for MNGIE and had homozygous or compound heterozygous TP mutations. All had drastically decreased TP activity [mean (SD), 10 (15) nmol thymine formed · h−1 · (mg protein)−1 vs 634 (217) nmol thymine formed · h−1 · (mg protein)−1 for the controls]. Relative to the control mean, TP activities were reduced to 35% in mutation carriers and 65% in MNGIE-like patients. All 25 MNGIE patients had detectable plasma dThd [8.6 (3.4) μmol/L] and dUrd [14.2 (4.4) μmol/L]. Controls, carriers, and MNGIE-like patients showed no detectable plasma dThd and dUrd. Conclusions:We propose a diagnostic algorithm based on the determination of plasma dThd and dUrd, TP activity in buffy coat, or both to make a definitive diagnosis of MNGIE. Increased concentrations of dThd (>3 μmol/L) and dUrd (>5 μmol/L) in plasma or a decrease in buffy coat TP activity to ≤8% relative to controls is sufficient to diagnose MNGIE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Statin Adverse Effects: A Review of the Literature and Evidence for a Mitochondrial Mechanism
Golomb, B. A., & Evans, M. A. (2008) · American Journal of Cardiovascular Drugs · doi:10.2165/0129784-200808060-00004 · Cited by 677
El-Hattab, A. W., & Scaglia, F. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0177-6 · Cited by 335
Clinical and genetic spectrum of mitochondrial neurogastrointestinal encephalomyopathy
Garone, C., Tadesse, S., & Hirano, M. (2011) · Brain · doi:10.1093/brain/awr245 · Cited by 217
“…New York, NY 10032, USA E-mail: mh29@columbia.edu Mitochondrial neurogastrointestinal encephalomyopathy is a rare multisystemic autosomic recessive disorder characterized by: onset typically before the age of 30 years; ptosis; progressive external ophthalmoplegia; gastrointestinal dysmotility;…”
BackgroundMethodInfluentialSelf-citationFilosto, M., Scarpelli, M., Tonin, P., Lucchini, G., Pavan, F., Santus, F., Parini, R., Donati, M. A., Cotelli, M. S., Vielmi, V., et al. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6572-9 · Cited by 64
“The diagnosis is confirmed by a family history consistent with autosomal recessive inheritance, high plasma and urine thymidine and deoxyuridine concentrations, reduced or absent TP enzyme activity in leukocytes and molecular genetic testing of TYMP [17, 18].”
BackgroundPitfalls in diagnosing mitochondrial neurogastrointestinal encephalomyopathy
Filosto, M., Scarpelli, M., Tonin, P., Testi, S., Cotelli, M. S., Rossi, M., Salvi, A., Grottolo, A., Vielmi, V., Todeschini, A., et al. (2011) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-011-9332-6 · Cited by 43
Vila-Julià, F., Cabrera-Pérez, R., Cámara, Y., Molina-Berenguer, M., Lope-Piedrafita, S., Hirano, M., Mingozzi, F., Torres-Torronteras, J., & Martí, R. (2020) · eBioMedicine · doi:10.1016/j.ebiom.2020.103133 · Cited by 22
Self-citation
Metadata
- Authors
- Martı́, R., Spinazzola, A., Tadesse, S., Nishino, I., Nishigaki, Y., & Hirano, M.
- Venue
- Clinical Chemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-01-01
- Volume
- 50
- Issue
- 1
- Pages
- 120-124
- ISSN
- 0009-9147 (ISSN-L)
- 1530-8561
- OpenAlex
- W2171560597
- Cited by
- 108
- References
- 0
- FWCI
- 2.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.